OptimizeRx Corporation expected to post earnings of 12 cents a share - Earnings Preview

OptimizeRx

10/08/2026 21:57

OptimizeRx Corporation OPRX.OQ OPRX.O is expected to  show a fall in quarterly revenue when it reports  results on August 12 for the period ending June 30 2026
The Waltham Massachusetts-based  company is expected to report a 30.8% decrease in revenue to $20.204 million from $29.2 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
​LSEG's mean analyst estimate for OptimizeRx Corporation is for earnings of 12 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for OptimizeRx Corporation is $11.00, about 55.4% above its last closing price of $7.08
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.01
0.00
0.14
Beat
4,104.2
Dec. 31 2026
0.23
0.23
0.51
Beat
125
Sep. 30 2025
0.04
0.04
0.20
Beat
351.6​
Jun. 30 2025
0.02
0.02
0.24
Beat
1,300.2
​​Mar. 31 2025
-0.13
-0.12
0.08
Beat
166.7
Dec. 31 2024
0.28
0.27
0.30
Beat
10.6​
Sep. 30 2024
0.06
0.06
0.12
Beat
94.5
Jun. 30 2024
-0.06
-0.06
0.02
Beat
131.3
This summary was machine generated August 10 at 20:57 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)